Towa Pharmaceutical Co (JP:4553) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Towa Pharmaceutical Co. has revised its financial forecasts upward for the fiscal year ending March 31, 2025, driven by strong overseas sales and lower-than-expected R&D expenses. The company now expects significant increases in profits and earnings per share due to favorable foreign exchange gains and operational efficiency.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.
